前列地尔联合依帕司他对糖尿病足患者创面肉芽组织TNF-α、IL-6、VEGF表达影响

doi:10.3969/j.issn.1000-8535.2018.02.003

广州医药 ›› 2018, Vol. 49 ›› Issue (2): 10-14.DOI: 10.3969/j.issn.1000-8535.2018.02.003

前列地尔联合依帕司他对糖尿病足患者创面肉芽组织TNF-α、IL-6、VEGF表达影响

黄余湘

广州市越秀区中医医院(广州 510030)

收稿日期:2017-09-27 出版日期:2018-03-20 发布日期:2021-12-01
基金资助:
广州市越秀区科技计划项目(2014-WS-034)

Effects of combination of alprostadil and epalatone on expression of TNF-α, IL-6 and VEGF in granulation tissue of patients with diabetic foot

HUANG Yuxiang

Guangzhou Yuexiu District Hospital of Traditional Chinese Medicine,Guangzhou 510030,China

Received:2017-09-27 Online:2018-03-20 Published:2021-12-01

摘要/Abstract

摘要： 目的探讨前列地尔联合依帕司他对糖尿病足患者创面肉芽组织肿瘤坏死因子(tumor necrosis factor-α,TNF-α)、白介素-6 (interleukin-6,IL-6)及血管内皮生长因子(vascular endothelial growth factor,VEGF)表达的影响。方法将90例糖尿病足患者随机分为研究组和对照组,每组45例,对照组予常规治疗,研究组在常规治疗基础上给予前列地尔+依帕司他联合治疗。监测两组患者创面愈合率,患肢足背血流动力学及腓总神经传导速度,创面肉芽组织TNF-α、IL-6、VEGF含量及基因表达变化。结果治疗后第2、4周研究组较对照组创面愈合率升高,差异有统计学意义(P<0.05);治疗后两组患者足背动脉血流动力学及腓总神经传导速度均有改善,而研究组疗效更明显(P<0.05);治疗后研究组患者创面肉芽组织TNF-α、IL-6含量及基因表达较对照组降低,VEGF含量及基因表达则升高(P<0.05)。结论前列地尔联合依帕司他联合治疗可改善糖尿病足患者足背动脉血流动力学,促进受损神经功能恢复;降低糖尿病足患者创面肉芽组织TNF-α、IL-6表达,减轻免疫损伤;增加VEGF基因表达,促进血管生成,加速创伤愈合。

关键词: 联合治疗, 糖尿病足, TNF-α, IL-6, VEG

Abstract: Objective To investigate the effects of alprostadil combined with epalrestat on the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in granulation tissue in patients with diabetic foot patients.Methods Totally 90 cases with diabetic foot were randomly divided into study group (45 cases)and control group(45 cases). The control group received conventional treatment for 4 weeks and the study group additionally received combination of alprostadil and epalatone for 4 weeks. The curative rate of wound healing, limb dorsal hemodynamics, peroneal nerve conduction velocity and the levels of TNF-α, IL-6 and VEGF in the granulation tissue of the wound were monitored in the two groups.Results The wound healing rate of the study group was significantly higher than that of the control group at the 2nd and 4th week after treatment (P<0.05). After treatment, the hemodynamics and peroneal nerve conduction velocity were improved (P<0.05). The contents and expressions of TNF-α and IL-6 in the granulation tissue of the treatment group were significantly lower than that of the control group, and the content of VEGF and gene expression were significantly increased in the study group (P<0.05).Conclusion The combination therapy of alprostadil and epalrestat may improve the hemodynamics of dorsalis pedis artery in patients with diabetic foot and promote the recovery of damaged nerve function.Also it may reduce the expression of TNF-α and IL-6 in the granulation tissue of diabetic patients and reduce the immune injury. It promotes angiogenesis and accelerates wound healing by increasing VEGF gene expression.

Key words: Combined therapy, Diabetic foot, TNF-α, IL-6, VEGF

黄余湘. 前列地尔联合依帕司他对糖尿病足患者创面肉芽组织TNF-α、IL-6、VEGF表达影响[J]. 广州医药, 2018, 49(2): 10-14.

HUANG Yuxiang. Effects of combination of alprostadil and epalatone on expression of TNF-α, IL-6 and VEGF in granulation tissue of patients with diabetic foot[J]. Guangzhou Medical Journal, 2018, 49(2): 10-14.

参考文献

[1] MORBACH S, MULLER E, REIKE H, et al. Diabetic foot syndrome[J]. Exp Clin Endocrinol Diabetes, 2014, 122(7): 416-424.
[2] ANDREWS K L, HOUDEK M T, KIEMELE L J. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine[J]. Prosthet Orthot Int, 2015, 39(1): 29-39.
[3] NOOR S, ZUBAIR M, AHMAD J. Diabetic foot ulcer-A review on pathophysiology, classification and microbial etiology[J]. Diabetes Metab Syndr, 2015, 9(3): 192-199.
[4] MARKAKIS K, BOWLING F L, BOULTON A J. The diabetic foot in 2015: an overview[J]. Diabetes Metab Res Rev, 2016, 32 Suppl 1: 169-178.
[5] FEITOSA M C, CARVALHO A F, FEITOSA V C, et al. Effects of the Low-Level Laser Therapy (LLLT) in the process of healing diabetic foot ulcers[J]. Acta Cir Bras, 2015, 30(12): 852-857.
[6] WELEDJI E P, FOKAM P. Treatment of the diabetic foot-to amputate or not?[J]. BMC Surg, 2014, 14: 83.
[7] LAZARO-MARTINEZ J L, ARAGON-SANCHEZ J, GA-RCIA-MORALES E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial[J]. Diabetes Care, 2014, 37(3): 789-795.
[8] TABUR S, EREN M A, CELIK Y, et al. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration[J]. Wien Klin Wochenschr, 2015, 127(1-2): 45-50.
[9] MARGOLIS D J, HAMPTON M, HOFFSTAD O, et al. Health literacy and diabetic foot ulcer healing[J]. Wound Repair Regen, 2015, 23(3): 299-301.
[10] JONES M S, RIVERA M, PUCCINELLI C L, et al. Targeted amino acid supplementation in diabetic foot wounds: pilot data and a review of the literature[J]. Surg Infect (Larchmt), 2014, 15(6): 708-712.
[11] AUGUSTIN A J, DIEHM C, GRIEGER F, et al. Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial[J]. Expert Opin Investig Drugs, 2013, 22(7): 803-812.
[12] REDDY T N, RAVINDER M, BAGUL P, et al. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs)[J]. Eur J Med Chem, 2014, 71: 53-66.
[13] GOMEZ-HERNANDEZ A, PERDOMO L, DE LAS HE-RAS N, et al. Antagonistic effect of TNF-alpha and insulin on uncoupling protein 2 (UCP-2) expression and vascular damage[J]. Cardiovasc Diabetol, 2014,13(1):108.
[14] TANAKA T, NARAZAKI M, KISHIMOTO T. IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harb Perspect Biol, 2014, 6(10): a016295.
[15] VEMPATI P, POPEL A S, MAC GABHANN F. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning[J]. Cytokine Growth Factor Rev, 2014, 25(1): 1-19.
[16] KAZMIERCZAK E, GRAJEK S, KOWAL J, et al. Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents[J]. Eur Rev Med Pharmacol Sci, 2014, 18(15): 2169-2175.

前列地尔联合依帕司他对糖尿病足患者创面肉芽组织TNF-α、IL-6、VEGF表达影响

Effects of combination of alprostadil and epalatone on expression of TNF-α, IL-6 and VEGF in granulation tissue of patients with diabetic foot

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	张琼, 黄淡銮, 尹玉珊. 大黄穴位贴联合直肠指力刺激治疗卒中后便秘的效果研究[J]. 广州医药, 2021, 52(6): 6-9.
[2]	刘思容, 荣新洲, 李庆辉. 糖尿病足患者创面病原菌分布及耐药性变迁[J]. 广州医药, 2018, 49(5): 81-85.
[3]	黄水庆. 2型糖尿病足部溃疡患者血栓素A2表达水平及相关因素研究[J]. 广州医药, 2016, 47(1): 57-58.
[4]	古智文, 潘小平, 张璐璐, 徐利敏, 陈丽萍, 李雪蓉, 曾贤威, 谢韫诗, 梁国强. 抑郁障碍患者血清IL-2和TNF-α水平与认知功能的相关性研究[J]. 广州医药, 2015, 46(4): 58-59.
[5]	伍丽琼, 杜洪. 乳腺癌VEGF－C的表达与淋巴结转移及预后的关系[J]. 广州医药, 2015, 46(1): 26-28.